CMTR1 and colorectal carcinoma: Consistently, the combination of CMTR1 knockdown and anti-PD1 treatment significantly inhibited CRC proliferation compared with CMTR1 knockdown or anti-PD1 treatment alone, as determined by immunostaining of ki67 (Fig. 6H, I).